Companies/Rocket Pharmaceuticals, Inc.

Company profile

Rocket Pharmaceuticals, Inc.

NASDAQ: RCKT · Healthcare · Biotechnology

PublicHQ Cranbury, NJ · MiddlesexCIK 0001281895Reports USD

#1161 of 1,418 Healthcare companies by revenue

EA Score

53D

FH 43DQ 64GM —SS 66

v0.1 · 55/100 weight · provisional

↑ balance-sheet leverage, filing timeliness · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$223.1M

Employees

202

as of 2026-08-12

Market cap

$382.2M

as of 2026-08-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$223.1M-$223.1M2025

Operating income-$231.7M-$231.7M2025

Total assets$330.4M$330.4M2025

Liabilities$53.2M$53.2M2025

Equity$277.2M$277.2M2025

Revenue trend

FY2020 – FY2025 · USD

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Rocket Pharmaceuticals, Inc.’s revenue?

Rocket Pharmaceuticals, Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Benitec Biopharma Inc.47D Larimar Therapeutics, Inc.38D Compass Therapeutics, Inc.50D Palisade Bio, Inc.71B SAB Biotherapeutics, Inc.52D Inhibikase Therapeutics, Inc.43D

Neighbors

Middlesex →

Johnson & Johnson$94.2B80B+Middlesex Water Company$194.7M63C Northfield Bancorp, Inc.$6.9M49D Outlook Therapeutics, Inc.$1.4M22D Magyar Bancorp, Inc.——Palatin Technologies, Inc.$040D

Key facts

CEOGaurav D. Shah

SectorHealthcare

IndustryBiotechnology

HeadquartersCranbury, NJ

ExchangeNASDAQ: RCKT

Employees202

IPO date2015-02-18

Latest filings

8-K2026-08-27 8-K2026-08-10 10-Q2026-08-10 8-K2026-08-03 8-K2026-06-30 8-K2026-06-12 8-K2026-05-21 8-K2026-05-07

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.